Articles

Vosaroxin in combination with decitabine in newly diagnosed older patients with acute myeloid leukemia or high-risk myelodysplastic syndrome

Department of Leukemia, The University of Texas M.D. Anderson Cancer Center, Houston, TX, USA
Department of Leukemia, The University of Texas M.D. Anderson Cancer Center, Houston, TX, USA
Department of Leukemia, The University of Texas M.D. Anderson Cancer Center, Houston, TX, USA
Department of Leukemia, The University of Texas M.D. Anderson Cancer Center, Houston, TX, USA
Department of Leukemia, The University of Texas M.D. Anderson Cancer Center, Houston, TX, USA
Department of Leukemia, The University of Texas M.D. Anderson Cancer Center, Houston, TX, USA
Department of Leukemia, The University of Texas M.D. Anderson Cancer Center, Houston, TX, USA
Department of Leukemia, The University of Texas M.D. Anderson Cancer Center, Houston, TX, USA
Department of Biostatistics, The University of Texas M.D. Anderson Cancer Center, Houston, TX, USA
Department of Biostatistics, The University of Texas M.D. Anderson Cancer Center, Houston, TX, USA
Department of Hematopathology, The University of Texas M.D. Anderson Cancer Center, Houston, TX, USA
Department of Hematopathology, The University of Texas M.D. Anderson Cancer Center, Houston, TX, USA
Department of Leukemia, The University of Texas M.D. Anderson Cancer Center, Houston, TX, USA
Department of Leukemia, The University of Texas M.D. Anderson Cancer Center, Houston, TX, USA
Department of Leukemia, The University of Texas M.D. Anderson Cancer Center, Houston, TX, USA
Department of Leukemia, The University of Texas M.D. Anderson Cancer Center, Houston, TX, USA
Department of Leukemia, The University of Texas M.D. Anderson Cancer Center, Houston, TX, USA
Department of Leukemia, The University of Texas M.D. Anderson Cancer Center, Houston, TX, USA
Sunesis Pharmaceuticals Inc., South San Francisco, CA, USA
Sunesis Pharmaceuticals Inc., South San Francisco, CA, USA
Department of Leukemia, The University of Texas M.D. Anderson Cancer Center, Houston, TX, USA
Vol. 102 No. 10 (2017): October, 2017 https://doi.org/10.3324/haematol.2017.168732